electroCore to Present at the Canaccord Genuity Growth Conference
Investors can register for the conference HERE.
Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website, www.electrocore.com.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Rich Cockrell CG Capital404-736-3838 email@example.com or Media Contact: Jackie DorskyelectroCore 908-313-6331 Jackie.firstname.lastname@example.org